Meridian Bioscience Company Profile (NASDAQ:VIVO)

About Meridian Bioscience

Meridian Bioscience logoMeridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers. Its segments include Diagnostics and Life Science. The Diagnostics segment includes manufacturing operations in Cincinnati, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America; Europe, the Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: VIVO
  • CUSIP: 58958410
Key Metrics:
  • Previous Close: $12.90
  • 50 Day Moving Average: $14.23
  • 200 Day Moving Average: $17.23
  • 52-Week Range: $10.75 - $21.49
  • Trailing P/E Ratio: 18.07
  • Foreward P/E Ratio: 18.33
  • P/E Growth: 1.15
  • Market Cap: $533.86M
  • Outstanding Shares: 42,202,000
  • Beta: 1
Profitability:
  • Net Margins: 15.13%
  • Return on Equity: 18.51%
  • Return on Assets: 12.23%
Debt:
  • Debt-to-Equity Ratio: 0.32%
  • Current Ratio: 5.99%
  • Quick Ratio: 3.87%
Additional Links:
Companies Related to Meridian Bioscience:

Analyst Ratings

Consensus Ratings for Meridian Bioscience (NASDAQ:VIVO) (?)
Ratings Breakdown: 1 Sell Rating, 4 Hold Ratings
Consensus Rating:Hold (Score: 1.80)
Consensus Price Target: $17.60 (39.13% upside)

Analysts' Ratings History for Meridian Bioscience (NASDAQ:VIVO)
Show:
DateFirmActionRatingPrice TargetDetails
1/31/2017Craig HallumDowngradeBuy -> HoldView Rating Details
1/25/2017Piper Jaffray CompaniesSet Price TargetSell$9.00View Rating Details
10/19/2016Canaccord GenuityReiterated RatingHold -> Neutral$18.00View Rating Details
7/29/2016Hilliard LyonsDowngradeBuy -> HoldView Rating Details
3/29/2016Robert W. BairdReiterated RatingHold$20.00View Rating Details
1/27/2016William BlairReiterated RatingMarket PerformView Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for Meridian Bioscience (NASDAQ:VIVO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2017        
1/25/2017Q1 2017$0.20$0.15$51.15 million$46.80 millionViewN/AView Earnings Details
11/10/2016Q4 2016$0.14$0.14$47.17 million$47.00 millionViewN/AView Earnings Details
7/28/2016Q3$0.22$0.21$52.85 million$50.70 millionViewN/AView Earnings Details
4/28/2016Q2$0.24$0.24$52.10 million$51.30 millionViewN/AView Earnings Details
1/27/2016Q1$0.21$0.21$48.60 million$47.20 millionViewN/AView Earnings Details
11/5/2015Q4$0.21$0.20$45.70 million$47.10 millionViewN/AView Earnings Details
7/23/2015Q3$0.22$0.22$48.60 million$48.20 millionViewN/AView Earnings Details
4/23/2015Q115$0.24$0.24$50.50 million$51.55 millionViewN/AView Earnings Details
1/22/2015Q414$0.19$0.19$46.20 million$48.00 millionViewN/AView Earnings Details
11/6/2014Q4$0.22$0.20$48.94 million$46.70 millionViewN/AView Earnings Details
7/24/2014Q3$0.22$0.21$47.96 million$47.20 millionViewN/AView Earnings Details
4/24/2014Q214$0.27$0.24$52.18 million$50.13 millionViewN/AView Earnings Details
1/22/2014Q114$0.18$0.18$47.59 million$44.80 millionViewN/AView Earnings Details
11/7/2013Q313$0.23$0.22$49.24 million$48.96 millionViewN/AView Earnings Details
7/25/2013Q3 2013$0.21$0.24$47.00 million$47.10 millionViewN/AView Earnings Details
4/25/2013Q2 2013$0.24$0.24$49.66 million$47.26 millionViewN/AView Earnings Details
1/23/2013Q1 2013$0.19$0.20$44.34 million$45.40 millionViewN/AView Earnings Details
11/8/2012Q412$0.19$0.21$43.22 million$43.70 millionViewN/AView Earnings Details
7/26/2012$0.22$0.21ViewN/AView Earnings Details
4/26/2012$0.21$0.23ViewN/AView Earnings Details
1/25/2012$0.19$0.17ViewN/AView Earnings Details
11/10/2011$0.19$0.18ViewN/AView Earnings Details
7/21/2011$0.21$0.17ViewN/AView Earnings Details
4/21/2011$0.20$0.20ViewN/AView Earnings Details
1/20/2011$0.19$0.15ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Meridian Bioscience (NASDAQ:VIVO)
Current Year EPS Consensus Estimate: $0.66 EPS
Next Year EPS Consensus Estimate: $0.69 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.24$0.25$0.25
Q2 20161$0.21$0.21$0.21
Q3 20161$0.20$0.20$0.20
Q1 20171$0.17$0.17$0.17
Q2 20171$0.22$0.22$0.22
Q3 20171$0.22$0.22$0.22
Q4 20171$0.20$0.20$0.20
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Meridian Bioscience (NASDAQ:VIVO)
Annual Dividend:$0.50
Dividend Yield:3.95%
Payout Ratio:71.43% (Based on Trailing 12 Months of Earnings)
75.76% (Based on Current Year Consensus EPS Estimate)
72.46% (Based on Next Year Consensus EPS Estimate)

Dividend History for Meridian Bioscience (NASDAQ:VIVO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/25/2017quarterly$0.133.91%2/2/20172/6/20172/16/2017
11/10/2016Quarterly$0.204.6%11/17/201611/21/201612/1/2016
7/28/2016quarterly$0.204.13%8/4/20168/8/20168/18/2016
4/28/2016quarterly$0.204.19%5/5/20165/9/20165/19/2016
1/27/2016quarterly$0.204.29%2/4/20162/8/20162/18/2016
11/5/2015quarterly$0.203.89%11/12/201511/16/201511/27/2015
7/23/2015quarterly$0.204.28%7/30/20158/3/20158/13/2015
4/23/2015quarterly$0.204.18%4/30/20155/4/20155/14/2015
1/22/2015quarterly$0.204.51%1/29/20152/2/20152/13/2015
11/6/2014quarterly$0.204.75%11/13/201411/17/201411/28/2014
7/24/2014quarterly$0.203.99%7/31/20148/4/20148/14/2014
4/24/2014quarterly$0.204.05%5/1/20145/5/20145/15/2014
1/22/2014quarterly$0.203.13%1/30/20142/3/20142/14/2014
11/7/2013quarterly$0.193.04%11/14/201311/18/201311/29/2013
7/25/2013quarterly$0.193.13%8/1/20138/5/20138/15/2013
4/25/2013quarterly$0.193.88%5/1/20135/4/20135/14/2013
12/4/2012quarterly$0.1912/14/201212/24/2012
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Meridian Bioscience (NASDAQ:VIVO)
Insider Ownership Percentage: 2.30%
Institutional Ownership Percentage: 87.90%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/2/2017Melissa LuekeCFOBuy4,000$12.59$50,360.00View SEC Filing  
1/26/2017Lawrence BaldiniEVPBuy4,000$12.70$50,800.00View SEC Filing  
12/2/2016Vecheslav A ElaginEVPSell7,883$17.30$136,375.90View SEC Filing  
11/30/2016Dwight E EllingwoodDirectorBuy1,020$17.12$17,462.40View SEC Filing  
11/16/2016Richard EberlyEVPSell4,926$17.00$83,742.00View SEC Filing  
11/4/2016John A KraeutlerChairmanBuy5,000$16.13$80,650.00View SEC Filing  
11/3/2016Lawrence BaldiniEVPBuy4,900$16.00$78,400.00View SEC Filing  
8/11/2016John McilwraithDirectorBuy1,000$19.57$19,570.00View SEC Filing  
4/29/2016Catherine SazdanoffDirectorBuy7,700$19.20$147,840.00View SEC Filing  
12/9/2015Vecheslav A ElaginEVPSell7,500$19.75$148,125.00View SEC Filing  
12/1/2015Richard EberlyEVPSell4,934$19.61$96,755.74View SEC Filing  
3/2/2015Marviette D JohnsonVPSell1,917$19.91$38,167.47View SEC Filing  
1/23/2015Dwight E EllingwoodDirectorBuy1,980$17.74$35,125.20View SEC Filing  
12/1/2014Susan RolihEVPSell11,219$16.46$184,664.74View SEC Filing  
11/21/2014Dwight E EllingwoodDirectorBuy1,000$16.08$16,080.00View SEC Filing  
11/18/2014John A KraeutlerCEOSell10,500$16.20$170,100.00View SEC Filing  
11/18/2014Melissa LuekeCFOSell6,713$16.20$108,750.60View SEC Filing  
11/11/2014David PhillipsDirectorBuy10,000$16.89$168,900.00View SEC Filing  
6/13/2014Robert J ReadyDirectorSell2,700$20.03$54,081.00View SEC Filing  
12/5/2013Vecheslav ElaginEVPSell4,141$23.74$98,307.34View SEC Filing  
11/22/2013Susan RolihEVPSell9,086$24.18$219,699.48View SEC Filing  
11/21/2013Richard EberlyEVPSell4,926$24.50$120,687.00View SEC Filing  
11/19/2013Lawrence BaldiniVPSell4,926$24.26$119,504.76View SEC Filing  
11/11/2013John KraeutlerCEOSell5,250$25.27$132,667.50View SEC Filing  
7/26/2013Lawrence BaldiniVPSell32,000$24.14$772,480.00View SEC Filing  
5/1/2013John A KraeutlerCEOBuy5,000$19.63$98,150.00View SEC Filing  
12/3/2012Lawrence BaldiniVPSell32,500$20.00$650,000.00View SEC Filing  
11/13/2012Robert J ReadyDirectorSell1,800$19.46$35,028.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Meridian Bioscience (NASDAQ:VIVO)
DateHeadline
finance.yahoo.com logoMERIDIAN BIOSCIENCE INC Financials (NASDAQ:VIVO)
finance.yahoo.com - February 17 at 6:14 AM
News IconNASDAQ:VIVO Shareholder News: Investigation over possible Securities Laws Violations by Meridian Bioscience, Inc. (NASDAQ:VIVO)
www.groundreport.com - February 10 at 8:40 PM
biz.yahoo.com logoMERIDIAN BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report (NASDAQ:VIVO)
biz.yahoo.com - February 10 at 6:29 AM
finance.yahoo.com logoBioline Launches New JetSeq™ DNA Library Preparation Kits (NASDAQ:VIVO)
finance.yahoo.com - February 9 at 6:32 AM
finance.yahoo.com logoBioline Launches New JetSeq(TM) DNA Library Preparation Kits (NASDAQ:VIVO)
finance.yahoo.com - February 9 at 6:32 AM
finance.yahoo.com logoPawar Law Group Announces Investigation of Securities Claims Against Meridian Bioscience, Inc. - VIVO (NASDAQ:VIVO)
finance.yahoo.com - February 7 at 3:33 PM
finance.yahoo.com logo10:56 am Meridian Bioscience launches TruQuick rapid tests for the diagnosis of tropical, infectious, sexually transmitted, respiratory, gastrointestinal, cancer, and cardiac diseases in Asia Pacific (NASDAQ:VIVO)
finance.yahoo.com - February 5 at 10:57 PM
us.rd.yahoo.com logoEQUITY ALERT: Rosen Law Firm Continues Investigation of Securities Claims Against Meridian Bioscience, Inc. - VIVO (NASDAQ:VIVO)
us.rd.yahoo.com - February 4 at 6:08 AM
finance.yahoo.com logoMeridian Bioscience Announces the Launch of TruQuick™ Rapid Tests for Asia Pacific (NASDAQ:VIVO)
finance.yahoo.com - February 4 at 6:08 AM
finance.yahoo.com logoMeridian Bioscience Announces the Launch of TruQuick(TM) Rapid Tests for Asia Pacific (NASDAQ:VIVO)
finance.yahoo.com - February 4 at 6:08 AM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Meridian Bioscience, Inc. and Encourages Investors with Losses to Contact the Firm (NASDAQ:VIVO)
finance.yahoo.com - February 4 at 6:08 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Meridian Bioscience, Inc. (NASDAQ:VIVO)
finance.yahoo.com - February 4 at 6:08 AM
finance.yahoo.com logoWhat Makes Meridian Bioscience (VIVO) a Strong Sell? (NASDAQ:VIVO)
finance.yahoo.com - February 3 at 6:37 AM
capitalcube.com logoETFs with exposure to Meridian Bioscience, Inc. : February 2, 2017 (NASDAQ:VIVO)
www.capitalcube.com - February 3 at 6:37 AM
sbwire.com logoInvestigation for Investors of Meridian Bioscience, Inc. (NASDAQ:VIVO) over Possible Violations of Securities Laws (NASDAQ:VIVO)
www.sbwire.com - January 31 at 3:30 PM
News IconEVP, Pres Global Operations of Meridian Bioscience Inc (NASDAQ:VIVO), Baldini Lawrence, buys 4,000 shares worth $50,800 (NASDAQ:VIVO)
empowerednews.net - January 30 at 8:44 PM
capitalcube.com logoMeridian Bioscience, Inc. :VIVO-US: Earnings Analysis: Q1, 2017 By the Numbers : January 26, 2017 (NASDAQ:VIVO)
us.rd.yahoo.com - January 27 at 9:13 PM
News IconMeridian Bioscience (VIVO) Releases Earnings Results, Misses Expectations By $-0.05 EPS (NASDAQ:VIVO)
flapship.com - January 27 at 6:35 AM
News IconThe Meridian Bioscience Inc. (VIVO) Receives Consensus Rating of "Hold" from Brokerages (NASDAQ:VIVO)
itapunta.com - January 27 at 6:35 AM
News IconMeridian Bioscience Inc. (NASDAQ:VIVO) Reviewed By Analysts (NASDAQ:VIVO)
prensariotiretail.com - January 27 at 6:35 AM
News IconSwiss National Bank Has $1283000 Stake in Meridian Bioscience Inc. (VIVO) (NASDAQ:VIVO)
nflnewsdesk.com - January 27 at 6:35 AM
News IconMeridian Bioscience Inc. (NASDAQ:VIVO) Under Analyst Spotlight (NASDAQ:VIVO)
xboxonezone.com - January 27 at 6:35 AM
us.rd.yahoo.com logoMeridian Bioscience Reports First Quarter 2017 Operating Results, Reduces Regular Cash Dividend, and Revises Fiscal 2017 Guidance Downward (NASDAQ:VIVO)
us.rd.yahoo.com - January 26 at 1:58 AM
4-traders.com logoGoldberg Law PC Announces an Investigation of Meridian Bioscience, Inc. and Advises Investors with Losses to Contact the Firm (NASDAQ:VIVO)
www.4-traders.com - January 25 at 8:57 PM
News IconHow Meridian Bioscience Inc (VIVO) Delivered A Better ROE Than Its Industry? (NASDAQ:VIVO)
simplywall.st - January 25 at 8:57 PM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Meridian Bioscience, Inc. (NASDAQ:VIVO)
finance.yahoo.com - January 25 at 8:57 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Meridian Bioscience, Inc. (VIVO) (NASDAQ:VIVO)
finance.yahoo.com - January 25 at 8:57 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Meridian Bioscience, Inc. and Advises Investors with Losses to Contact the Firm (NASDAQ:VIVO)
finance.yahoo.com - January 25 at 8:57 PM
rttnews.com logoMeridian Bioscience Q1 Results Miss View; Cuts Dividend And FY17 Outlook (NASDAQ:VIVO)
www.rttnews.com - January 25 at 3:56 PM
marketwatch.com logoMeridian Bioscience stock drops 9% on first-quarter earnings and revenue misses, guidance cuts and cash dividend reduction (NASDAQ:VIVO)
www.marketwatch.com - January 25 at 3:56 PM
cnbc.com logoMeridian Bioscience misses Street 1Q forecasts (NASDAQ:VIVO)
www.cnbc.com - January 25 at 3:56 PM
fool.com logoHere's Why Meridian Bioscience, Inc. Stock Is Having a Rough Day (NASDAQ:VIVO)
www.fool.com - January 25 at 1:25 PM
seekingalpha.com logoMeridian Bioscience earnings off 29%; lowers 2017 guidance; shares down 12% premarket (NASDAQ:VIVO)
seekingalpha.com - January 25 at 8:49 AM
capitalcube.com logoMeridian Bioscience, Inc. – Value Analysis (NASDAQ:VIVO) : January 13, 2017 (NASDAQ:VIVO)
www.capitalcube.com - January 13 at 3:39 PM
News IconMicrobix Biosystems Inc. Release: Company Appoints Meridian Life Science As Distributor In Asia Pacific (NASDAQ:VIVO)
www.biospace.com - January 12 at 3:48 PM
capitalcube.com logoMeridian Bioscience, Inc. breached its 50 day moving average in a Bearish Manner : VIVO-US : January 12, 2017 (NASDAQ:VIVO)
www.capitalcube.com - January 12 at 3:48 PM
finanznachrichten.de logoMeridian Bioscience, Inc.: Bioline Launches the Full Range of EPIK miRNA Assays (NASDAQ:VIVO)
www.finanznachrichten.de - January 9 at 3:50 PM
News IconMeridian Bioscience Inc VIVO Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:VIVO)
www.bioportfolio.com - January 9 at 3:50 PM
finance.yahoo.com logoBioline Launches the Full Range of EPIK™ miRNA Assays (NASDAQ:VIVO)
finance.yahoo.com - January 9 at 3:50 PM
finance.yahoo.com logoBioline Launches the Full Range of EPIK(TM) miRNA Assays (NASDAQ:VIVO)
finance.yahoo.com - January 9 at 3:50 PM
streetinsider.com logoMeridian Bioscience (VIVO) Signs Deal with MedCaptain Medical to Expand in China (NASDAQ:VIVO)
www.streetinsider.com - December 21 at 3:25 PM
capitalcube.com logoETFs with exposure to Meridian Bioscience, Inc. : December 21, 2016 (NASDAQ:VIVO)
www.capitalcube.com - December 21 at 3:25 PM
us.rd.yahoo.com logo2:00 pm Meridian Bioscience signs an exclusive distribution agreement with MedCaptain Medical Technology (NASDAQ:VIVO)
us.rd.yahoo.com - December 21 at 11:24 AM
capitalcube.com logoMeridian Bioscience, Inc. breached its 50 day moving average in a Bullish Manner : VIVO-US : December 6, 2016 (NASDAQ:VIVO)
www.capitalcube.com - December 6 at 9:28 AM
capitalcube.com logoETFs with exposure to Meridian Bioscience, Inc. : December 5, 2016 (NASDAQ:VIVO)
www.capitalcube.com - December 5 at 3:44 PM
News IconMeridian Bioscience, Inc. VIVO Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:VIVO)
www.bioportfolio.com - December 5 at 8:24 AM
News IconIs Meridian Bioscience, Inc. (VIVO) A Good Stock To Buy? (NASDAQ:VIVO)
feedproxy.google.com - December 3 at 10:36 PM
capitalcube.com logoMeridian Bioscience, Inc. :VIVO-US: Earnings Analysis: 2016 By the Numbers : December 1, 2016 (NASDAQ:VIVO)
www.capitalcube.com - December 1 at 9:02 PM
biz.yahoo.com logoMERIDIAN BIOSCIENCE INC Files SEC form 10-K, Annual Report (NASDAQ:VIVO)
biz.yahoo.com - November 29 at 4:04 PM
News IconMeridian Bioscience, Inc. VIVO Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:VIVO)
www.bioportfolio.com - November 20 at 7:45 PM

Social

What is Meridian Bioscience's stock symbol?

Meridian Bioscience trades on the NASDAQ under the ticker symbol "VIVO."

How often does Meridian Bioscience pay dividends? What is the dividend yield for Meridian Bioscience?

Meridian Bioscience declared a quarterly dividend on Wednesday, January 25th. Investors of record on Monday, February 6th will be paid a dividend of $0.125 per share on Thursday, February 16th. This represents a $0.50 annualized dividend and a yield of 3.95%. The ex-dividend date is Thursday, February 2nd.

Where is Meridian Bioscience's stock going? Where will Meridian Bioscience's stock price be in 2017?

5 brokers have issued 12-month price objectives for Meridian Bioscience's stock. Their predictions range from $9.00 to $22.00. On average, they expect Meridian Bioscience's stock price to reach $17.60 in the next twelve months.

When will Meridian Bioscience announce their earnings?

Meridian Bioscience is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.

Who owns Meridian Bioscience stock?

Meridian Bioscience's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Brown Capital Management LLC (13.52%), Renaissance Technologies LLC (4.44%), Dimensional Fund Advisors LP (3.32%), State Street Corp (2.57%), Prudential PLC (2.42%) and Fred Alger Management Inc. (0.92%). Company insiders that own Meridian Bioscience stock include Catherine Sazdanoff, Dwight E Ellingwood, John A Kraeutler, John Mcilwraith, Lawrence Baldini, Marviette D Johnson, Melissa Lueke, Richard Eberly and Vecheslav A Elagin.

Who sold Meridian Bioscience stock? Who is selling Meridian Bioscience stock?

Meridian Bioscience's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, AQR Capital Management LLC, Brown Capital Management LLC, Guggenheim Capital LLC, Keybank National Association OH, Tudor Investment Corp Et Al, State Board of Administration of Florida Retirement System and Numeric Investors LLC. Company insiders that have sold Meridian Bioscience stock in the last year include Richard Eberly and Vecheslav A Elagin.

Who bought Meridian Bioscience stock? Who is buying Meridian Bioscience stock?

Meridian Bioscience's stock was acquired by a variety of institutional investors in the last quarter, including Discovery Group I LLC, State Street Corp, FMR LLC, Flinton Capital Management LLC, Two Sigma Investments LP, Tyers Asset Management LLC, Fred Alger Management Inc. and Royce & Associates LP. Company insiders that have bought Meridian Bioscience stock in the last two years include Catherine Sazdanoff, Dwight E Ellingwood, John A Kraeutler, John Mcilwraith, Lawrence Baldini and Melissa Lueke.

How do I buy Meridian Bioscience stock?

Shares of Meridian Bioscience can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Meridian Bioscience stock cost?

One share of Meridian Bioscience stock can currently be purchased for approximately $12.65.

Meridian Bioscience (NASDAQ:VIVO) Chart for Saturday, February, 25, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Meridian Bioscience (NASDAQ:VIVO)

Earnings History Chart

Earnings by Quarter for Meridian Bioscience (NASDAQ:VIVO)

Dividend History Chart

Dividend Payments by Quarter for Meridian Bioscience (NASDAQ:VIVO)

Last Updated on 2/25/2017 by MarketBeat.com Staff